## Clinical Diagnosis: Optic Neuritis (Papillitis) ### Key Distinguishing Features **Key Point:** Optic neuritis presents with acute unilateral vision loss, pain on eye movement (retrobulbar inflammation), and central scotoma — all present in this case. ### Differential Diagnosis: Papilloedema vs Papillitis | Feature | Papilloedema | Papillitis (Optic Neuritis) | |---------|--------------|-----------------------------| | **Onset** | Insidious, progressive | Acute (hours to days) | | **Pain** | Absent or mild | Prominent, worse with eye movement | | **Vision loss** | Late finding, peripheral first | Early and central (scotoma) | | **Scotoma** | Arcuate or peripheral | Central scotoma | | **Bilaterality** | Bilateral (raised ICP affects both) | Unilateral | | **Disc appearance** | Blurred margins, hyperaemia, exudates, hemorrhages | Hyperaemia, swelling, may be less hemorrhage | | **Pupil** | Normal or sluggish | Relative afferent pupillary defect (RAPD) | | **MRI** | Brain shows mass/edema/hydrocephalus | Optic nerve T2 hyperintensity | | **Prognosis** | Depends on underlying cause | Good recovery, but MS risk ~50% in 15 years | **High-Yield:** The combination of **acute unilateral pain with eye movement + central scotoma + optic disc swelling = papillitis**, not papilloedema. ### Why This Is Papillitis 1. **Pain on eye movement** — pathognomonic for retrobulbar inflammation; papilloedema is painless. 2. **Central scotoma** — indicates optic nerve axon involvement; papilloedema causes peripheral or arcuate defects. 3. **Unilateral presentation** — papilloedema is bilateral (raised ICP). 4. **MRI optic nerve hyperintensity** — confirms inflammatory demyelination of the optic nerve. 5. **Acute onset** — papilloedema develops insidiously over weeks. ### Clinical Pearl **Clinical Pearl:** Optic neuritis is the presenting feature of multiple sclerosis in ~25% of MS patients. This 28-year-old woman has a 50% risk of developing MS within 15 years; brain MRI should be obtained to assess for demyelinating lesions. ### Management - High-dose IV methylprednisolone 1 g daily × 3 days (Optic Neuritis Treatment Trial evidence). - Visual evoked potentials (VEP) — delayed latency confirms demyelination. - Brain MRI to assess MS risk. - Baseline ophthalmology review and follow-up. [cite:Harrison 21e Ch 428] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.